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The brain’s impotence to utilize long-chain fatty acids as fuel, one of the dogmas in neuroscience, is
surprising, since the nervous system is the tissue most energy consuming and most vulnerable to a lack of
energy. Challenging this view, we here show in vivo that loss of the Drosophila carnitine
palmitoyltransferase 2 (CPT2), an enzyme required for mitochondrial b-oxidation of long-chain fatty acids
as substrates for energy production, results in the accumulation of triacylglyceride-filled lipid droplets in
adult Drosophila brain but not in obesity. CPT2 rescue in glial cells alone is sufficient to restore
triacylglyceride homeostasis, and we suggest that this is mediated by the release of ketone bodies from the
rescued glial cells. These results demonstrate that the adult brain is able to catabolize fatty acids for cellular
energy production.
T
o guarantee organismal survival, a continuous supply of ATP for cellular energy production ismaintained by
many regulatory mechanisms at the cellular, endocrine and behavioral level. Under normal feeding condi-
tions, ATP is generated from different substrates, such as carbohydrates, amino and fatty acids, delivered to
the various tissues via the circulation. When calories are oversupplied, triacylglycerides (TAG) are synthesized
from the different substrates and stored in specific cells, so called adipocytes. Excess body TAG storage is called
obesity, a condition that is linked to increased morbidity and mortality. During prolonged starvation, cellular
TAGmobilization and catabolism becomes vital. The long-chain fatty acid (LCFA) groups are released from the
glycerol backbone and activated with a Coenzyme A (CoA) residue. LCFA-CoA is catabolized through b2oxida-
tion, either in mitochondria or in peroxisomes, but only mitochondrial b-oxidation is coupled to ATP produc-
tion1. LCFA-CoA does not cross the tight inner mitochondrial membrane: to cross, the CoA residue is replaced
with a carnitine residue, a reaction that is catalyzed by carnitine palmitoyltransferase 1 (CPT1). LCFA-carnitine is
transported with carnitine-acylcarnitine translocase (CACT) across the inner membrane. Inside mitochondria,
carnitine needs to be replaced again by CoA, a reaction catalyzed by carnitine palmitoyltransferase 2 (CPT2),
yielding LFCA-CoA that can be catabolized through b2oxidation and generate ATP2–4.
Human patients with severe mutations in one of the enzymes of the carnitine shuttle system, CPT1 or CPT2,
die early after birth. Patients with less severemutations are sensitive to starvation throughout life. This is probably
a direct consequence of the failure to generate ATP through the TAG-b2oxidation pathway5,6 and illustrates the
critical importance of this pathway.
Although CPT2 deficiency patients have brain defects7,8, and CPT1 and CPT2 expression has been demon-
strated in adult brain5,9, it has been stated that the brain does not use b2oxidation for energy production10. In fact,
under conditions of starvation brain metabolism is thought to be restricted to use ketone bodies derived from b-
oxidation of long-chain fatty acids in the liver. It has been argued that the reason behind this might be that
b2oxidation11 is associated with the production of free oxygen radicals, causing neuronal loss. While liver or
muscle cells, where b2oxidation occurs at high rates during starvation, are replaceable, brain cells are post-
mitotic, unique in terms of circuitry and therefore not easily, if at all, replaceable. Another reason for the denial of
b2oxidation in the brain may reside in the limited space in the scull or head capsule to allow for extensive lipid
storage without compromising brain function.
To challenge the view that the brain does not use long chain fatty acids for energy production, we here directly
tested the contribution of the brain in organismal b2oxidation by removing dCPT2 inDrosophila melanogaster.
Our results show that b2oxidation does in fact occur in the glial cells of the adult Drosophila brain in vivo and
may contribute to organismal energy supply.
OPEN
SUBJECT AREAS:
NEURODEVELOPMENTAL
DISORDERS
CELLULAR NEUROSCIENCE
PAEDIATRIC NEUROLOGICAL
DISORDERS
Received
9 July 2014
Accepted
3 December 2014
Published
15 January 2015
Correspondence and
requests for materials
should be addressed to
J.G.S. (joachim.
schulz@uk-essen.de) or
C.G.D. (cdotti@cbm.
csic.es)
SCIENTIFIC REPORTS | 5 : 7805 | DOI: 10.1038/srep07805 1
Results
Drosophila CPT2 deficiency resembles human CPT2 deficiency.
To determine the importance of fatty acid catabolism for energy
production in brain, we searched the Drosophila melanogaster
genome for the orthologue of the highly conserved bottleneck
enzyme of b-oxidation, carnitine palmitoyltransferase 2 (CPT2).
Based on BLAST search on the Drosophila genome, we identified
CG2107, from now on called dCPT2 (Fig. 1a), on chromosome 3L,
and generated loss-of function alleles by imprecise excision of
P-element P(GSV7)GS21694 situated in the 59 UTR of the only
dCPT2 transcript, 92 base pairs before the translational start site.
Two mutant alleles, dCPT2d3 and dCPT2d18, we considered null
mutants, since a major part of the ORF (508 and 124 of the 667
amino acids, respectively) was deleted (Fig. 1b), and both mutants
failed to complement each other, or Deficiencies Df(3L)BSC428 and
Df(3L)BSC671 spanning the CG2107 locus (Fig. 1c). As wild type
control line in our experiments we used the revertant line giving rise
to a precise excision of P(GSV7)GS21694.
The majority (62%) of the dCPT2d3 mutant flies died within the
first three days after eclosion, reminiscent of the postnatal lethality in
severe human CPT2 deficiency patients. This phenotype was fully
rescued with ubiquitous expression of wild type rat CPT2 (rCPT2) (p
5 0.0003), but not with inactive rat CPT2 bearing the H372A muta-
tion of the catalytic site that gives rise to human disease12 (Fig. 1c).
This confirms that CG2107 is indeed orthologous to mammalian
CPT2, and that dCPT2d3, from now on called dCPT22/2, specifically
affects dCPT2. The ectopic expression of rat CPT2 in flies was con-
firmed by Western blot (Fig. 1d).
dCPT2 is required in adult life. Developmental analysis showed
that most of the dCPT22/2 lethality occurred in the first three days
after eclosion (p 5 0.003), and very little during larval or pupal
development (Fig. 2a). dCPT22/2 flies that survived the immediate
post-eclosion period still showed a severely reduced adult lifespan of
22 and 10 days in females and males, respectively, compared to 47
and 42 days in control females and males (Fig. 2b). The reduced
lifespan could be fully reversed by ubiquitous rescue of CPT2. This
indicates that flies require b-oxidation for survival during adulthood.
Another core symptom of human CPT2 deficiency in adults is
sensitivity to starvation. Similar to human CPT2 deficiency patients,
dCPT22/2 flies were hypersensitive to starvation. Under conditions
of complete starvation, the average survival time of dCPT22/2 flies
dropped from 63.11/2 7.5 hours to 37.51/2 2.6 hours in female
(p5 0.005) and from 32.01/2 3.4 to 21.31/2 3.3 hours inmale (p
5 0.017) dCPT22/2 flies when compared to wild type (Fig. 2c).
No obesity but brain TAG accumulation in adult dCPT22/2 flies.
We asked if systemic lack of mitochondrial b-oxidation causes
obesity, since it is the main pathway for long-chain fatty acid
(LCFA) degradation. In contrast to our expectations, normally fed
dCPT22/2 flies were not heavier (Fig. 2d) but even lighter than
controls, 0.72 1/2 0.04 mg vs. 0.67 1/2 0.04 mg for male (p 5
0.02) and 1.04 1/2 0.05 mg vs. 0.97 1/2 0.02 mg for female (p 5
0.002) wild type vs. dCPT22/2 flies, respectively. Body lengthwas also
somewhat reduced in dCPT22/2 flies when compared to controls
(2.70 1/2 0.13 vs. 2.61 1/2 0.08 mm in female (p 5 0.02) and
2.251/2 0.11 mm vs. 2.231/2 0.16 mm in male (not significant)
wild type vs. dCPT22/2 flies, respectively (Fig. 2e), but the ratio of
weight and size (BMI) was not increased in dCPT22/2 flies (Fig. 2f).
Motor activity over a period of 24 h was also unchanged, reaching
from 469 1/2 63 beam passes in control to 535 1/2 70 in
heterozygotes to 538 1/2 80 in dCPT22/2 homozygotes (Fig. 2g),
ruling out increased muscle work as the cause for the lack of an
obesity phenotype in dCPT22/2 animals. Together this suggests
that in Drosophila the regulation of energy balance is independent
from mitochondrial b-oxidation.
Whole body neutral lipid was not increased in fed dCPT22/2 flies.
In fed male dCPT22/2 flies, TAG levels were identical in both
dCPT22/2 and wild type flies. In fed female dCPT22/2 flies, TAG
levels were even lower than in wild type controls (Fig. 3a). Total
TAG was turned over at the same rate in dCPT22/2 and wild type
flies under starvation conditions (Fig. 3a). This result further
strengthens the notion that pathways other than mitochondrial b-
oxidation regulate TAG turnover at the organismal level.
Yet, although TAG levels were not increased in the body of
dCPT22/2 flies, TAG accumulated massively in dCPT22/2 brains.
Consistent with what is known frommammalian brains, in wild type
brains TAGwas barely detectable (Fig. 3b, c). TAG levels in wild type
fly brain were at the detection limit of 13.4 pmol per brain, while
reaching 235.1 pmol TAG per dCPT22/2 brain, equivalent to a
17.5 fold increase (p 5 0.0004). Brain phospholipid levels were
unchanged, ruling out a simple increase in brain size, brain degen-
eration or loss of brain tissue due to the lack of dCPT2.
In order to validate and further understand the nature of the TAG
accumulations in dCPT22/2 brains, we performed brain whole
mount staining with a neutral lipid specific dye13. This confirmed
widespread accumulation of neutral lipid droplets in dCPT22/2
brains, while basically no signal was obtained from wild type brains
(Fig. 3d, middle panel). Similar results were obtained from fly brains
mutant for dCPT1 (Fig. 3d, right panel), another bottle-neck enzyme
required for mitochondrial b-oxidation, giving rise to a similar
human phenotype. Interestingly, lipid droplets also accumulated in
flight muscle (Fig. 3d).
Finally, electron microscopy images from dCPT22/2 but not con-
trol brains showed frequent droplet-like inclusions of homogenous
appearance, a single outer membrane, and variable size, character-
istic for TAG containing lipid droplets (Fig. 3e).
Altogether, the last series of results demonstrates massive accu-
mulation of TAG-filled lipid droplets in the brains and muscle of
dCPT22/2 animals while total body TAG levels or body were not
increased in dCPT22/2 animals.
Glial b-oxidation restores lipid homeostasis. We analyzed next if
dCPT2 is expressed in the adult fly brain. Using a knock in line where
GFP is fused to dCPT2 in the dCPT2 locus, we could demonstrate
endogenous expression of dCPT2 in the brain by confocal
microscopy (Supplementary data). Knockdown of dCPT2 by RNA
interference specifically in neurons or glia caused a decrease of
dCPT2 transcript levels to 67% and 28% of control levels in brain,
respectively (Fig. 4a). Considering that in Drosophila the large
majority of brain cells are neurons this suggests that in adult fly
brain dCPT2 is expressed predominantly in glia and the brain
TAG deposits in dCPT22/2 flies are located in glial cells.
To prove this point, we ectopically expressed lipid storage droplet-
2 (LSD-2), a molecular marker for lipid droplets14 specifically in
neurons or glia by driving UAS-LSD-2 with Nsyb-Gal4 or Repo-
Gal4, respectively, and analyzed the brains of adult flies by confocal
microscopy. We found co-localization of LSD-2 with TAG deposits
in glia but not neurons of dCPT22/2 flies (Fig. 4b), demonstrating
stabilization of LSD-2 in lipid droplets in glia but not in neurons.
Is glial b-oxidation functionally relevant? To answer this, we per-
formed glial-specific dCPT2 rescue experiments. Glial-specific res-
cue of dCPT22/2 flies reversed brain TAG accumulation (Fig. 4c) and
peri-eclosion lethality (p 5 0.0009) (Fig. 4d), and normalized life-
span partially (Fig. 4e).
To specify further the role of dCPT2 in glial cells, we performed
rescue experiments in subpopulations of glial cells of dCPT22/2
flies15,16. This revealed that dCPT2 expression in cortex glia
(NP2222-Gal4; p 5 0.004 and Nrv2-Gal4; p 5 0.0009) or astro-
cyte-like glia (dEAAT1-Gal4; p 5 0.0005) but not in ensheathing
glia (NP6520) is sufficient to restore eclosion of dCPT2 mutants
(Fig. 4f).
www.nature.com/scientificreports
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Figure 1 | CG2107 mutants and rescue with mammalian CPT2. (A) Protein sequence alignment ofDrosophila melanogaster (DM),Drosophila simulans
(Dsim),Drosophila pseudoobscura (Dpse),Danio rerio (danio), gallus gallus (chick), homo sapiens (human),musmusculus (mouse), rattus norvegicus (rat)
and consensus CPT2. (B) Region 63A2 of Drosophila melanogaster chromosome 3L, bearing dCPT2 (CG2107), P-element insertions, deficiencies
Df(3l)428 and Df(3L)671 spanning the CG2107 locus, and the sequences deleted in two newly generated mutants dCPT2 d18 and d3. (C) Eclosion rates of
dCPT2 mutant flies with the indicated genotypes in percent of expected (n.5 3 experiments, **** p, 0.0001). Rescue was performed with wild type
(rCPT2) ormutant (rCPT2 H372A) rat CPT driven by the ubiquitous driver da-Gal4. (D)Western blot frommouse liver or whole fly extract fromwild type
or rCPT2 expressing flies, stained with anti-CPT2 to confirm ectopic expression in rescue flies (65 kDa bandmarked with an arrow), or anti-Histone 3 as
loading control.
www.nature.com/scientificreports
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Figure 2 | Phenotype of dCPT22/2 animals. (A) Percent survival of wild type (Rev) or dCPT22/2 larvae, pupae or young adults, in percent (n .5 3
experiments; ** p , 0.01; ***p , 0.005). (B) Lifespan of wild type or dCPT22/2 adults with or without ubiquitous rescue with rCPT2, in days 1/2
standard error of the means (n.5 4 experiment for a total of.5105 animals per genotype). (C) Percent survival of starving 1 week old adults on 1%
agarose, in hours1/2 standard error of the means (n5 3 for a total of.5209 animals per genotype). (D)Weight per adult fly, in mg (n.5 394; * p,
0.05; ***p, 0.005)). (E) Length of adult flies, inmm (n5 10). (F) Ratio of weight per length inmg/mm. (G) Total motor activity time of adultmale flies,
in counts per 24 h (n 5 6).
www.nature.com/scientificreports
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Figure 3 | Lipid composition of dCPT22/2 flies and TAG accumulation in dCPT22/2 brains. (A) Protein, phospholipid (PL) and triacylglyceride
(TAG) content of 1 week old adult female flies of the indicated genotype after the indicated hours of starvation (n5 3 experiments). (B) Phospholipid
(PL) and triacylglyceride (TAG) content of 1 week old female adult brains of the indicated phenotype (n5 3 experiments, ***p, 0.001). (C) Thin layer
chromatography of lipid extracts of dCPT22/2 or wild type brains, fatty acid (FA; oleic acid), diacylglyceride (DAG; 1,2-diolein) and triacylglyceride
(TAG, triolein) as standards. (D) Confocal micrograph of adult brains or flight muscle of the indicated genotype, stained with neutral lipid staining (red).
(E) Electron micrograph of wild type or dCPT22/2 brain showing accumulation of TAG in dCPT22/2 brain marked with arrows.
www.nature.com/scientificreports
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Figure 4 | TAG localization in glial lipid droplets and contribution to organismal lipid metabolism. (A) Relative expression levels of dCPT2 mRNA in
adult brain after specific knockdown in neurons (Nsyb-Gal4) or glia (Repo-Gal4) (n 5 3 experiments). (B) Confocal micrograph of adult dCPT22/2
brains expressing LSD2-GFP (in green) in neurons (Nsyb-Gal4) (upper row) or glia (Repo-Gal4) (lower row) and stainedwith neutral lipid staining (NLS)
(red). (C) Confocal micrograph of adult brains and muscle from dCPT22/2 or dCPT22/2 with glial dCPT2 rescue (lower) flies stained with neutral
lipid staining (red). (D) Eclosion viability of dCPT22/2 flies or dCPT22/2 flies with dCPT2 rescue in glia (Repo-Gal4), muscle (Mef2-Gal4), fat body
(Cg-Gal4) or neurons (Nsyb-Gal4) (n5 3 experiments, ***p, 0.001). (E) Lifespan of male or female wild type or dCPT22/2 adults with or without glial
rescue with rCPT2, in days1/2 standard error of the means (n.5 57 flies). (F) Eclosion viability of dCPT22/2 flies or dCPT22/2 flies with dCPT2
rescue with the indicated glial subtype driver (n 5 4 experiments, ***p , 0.001). (G) qPCR results for the indicated transcripts involved in different
metabolic pathways, from RNA extracted from heads of the indicated genotypes with or without 24 h starvation (ratio starved/nonstarved) (n 5 3
experiments, ***p , 0.01). (H) qPCR results for the indicated transcripts involved in ketone body formation, from RNA extracted from heads of the
indicated genotypes with or without 24 h starvation (ratio starved/nonstarved) (n 5 3 experiments, *p , 0.05).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 7805 | DOI: 10.1038/srep07805 6
To analyzewhichmetabolic changes underlie glial dCPT22/2 func-
tion, we compared expression levels of different genes involved in
b2oxidation, lipogenesis and gluconeogenesis in heads of starved or
non-starved adult wild type, dCPT22/2, dCPT22/2 with glial dCPT2
rescue, and dCPT22/2 with muscular dCPT2 rescue flies. We found
that HNF4, the master regulator of the b2oxidation transcriptional
program17 was up regulated 1.6 fold in heads of dCPT22/2 glial rescue
flies (p5 0.001), but down regulated in heads of wild type (Fig. 4g),
dCPT22/2, or dCPT22/2 flies with muscular rescue, suggesting that
the rescued glial cells perform b-oxidation. In contrast, the glial
rescue flies did not induce lipogenesis, since SREBP levels remained
constant, and gluconeogenesis was blocked, as indicated by the
increase in PEPK levels (p 5 0.006).
How would b-oxidation restricted to glia provide energy to other
cells such as neurons or muscle? This could happen in a manner
similar to ketone body production in the mammalian liver, where
this pathway is up regulated under starvation conditions. Thus we
tested the brain for expressional changes of enzymes involved in
ketone body generation. Strikingly, all four different enzymes
involved in ketone body formation (HMGL, HMGS, CG1140 and
CG13377) were up regulated 1.7 to 2.0 fold in dCPT22/2 flies with
glial rescue (p 5 0.02 to 0.03), but not in wild type, dCPT22/2 or
muscular rescue flies (Fig. 4h). This suggests that glial cells can pro-
vide energy to the organism by generation and export of ketone
bodies derived from b-oxidation.
Discussion
The brain is a metabolically highly active tissue andmore sensitive to
nutrient and oxygen deprivation than any other organ. In fact, irre-
versible damage occurs already after minutes of hypoglycemia or
ischemia18, while other organs survive for hours. Yet, a central dogma
in biology is that b2oxidation of long-chain fatty acids (LCFA), an
important source of ATP provision under starvation conditions, is
completely absent from brain. Triacylglycerides (TAG) from which
LCFA arise are also thought to be absent from this organ.
However, a number of observations challenge the dogma. First, the
enzymes involved in mitochondrial b2oxidation are expressed in
adult brain9. Second, individuals affected by a mutation in CPT2, an
enzyme required for b2oxidation, have a morphological brain
phenotype7. Third, glial cells such as astrocytes are known to have
a potential to provide metabolites such as lactate to neurons19.
Fourth, neurons and glia are known to be able to store TAG under
certain in vitro conditions20.
These reasons prompted us to investigate the potential of the brain
to perform b2oxidation. We chose to study this under complete
absence of b2oxidation in the whole organism, assuming that this
might reveal b2oxidation induction deficits in the brain. We used
the fruit fly as an animal model that is genetically tractable and
created CPT22/2 flies. Those flies showed a phenotype reminiscent
of human CPT2 deficiency. They die shortly after birth; the survivors
have a reduced lifespan and are hypersensitive to starvation.
In support of our predictions, we could now demonstrate that
CPT2 is expressed in the brain, mostly in glia. CPT22/2 but not wild
type brains accumulated large amounts of TAG within lipid droplets
in vivo, a phenomenon that has been observed only in vitro so far20.
Detailed analysis demonstrated specific localization in glial cells,
supporting their role as nurturing cells. To test the functional
importance of glial cells in b2oxidation, we generated CPT22/2
animals in which CPT2 was rescued in glial cells only. This had both
cell autonomous and non-autonomous effects. Autonomously, glial
TAG accumulation was completely abolished, indicating that LCFA
are degraded in glia and that glial cells are indeed capable of perform-
ing b2oxidation. Non-autonomously, organismal lethality andTAG
accumulation in muscle is reversed. This could be mediated by an
effect on the brain directly, causing improved brain function.
Alternatively, glial cells could release energy metabolites such as
ketone bodies back into the hemolymph for systemic use21. In sup-
port of the latter possibility, we found that enzymes involved in
ketone body formation are up regulated in starving brains expressing
CPT2 only in glia. This result is in turn consistent with early work
showing that astrocytes in culture have the potential to produce
ketone bodies from fatty acids22, altogether suggestive that the adult
brain, under special circumstances like starvation, may act as a coor-
dinator of organismal energy metabolism23.
Interestingly, CPT22/2 flies are not obese. This suggests that
b2oxidation is not rate limiting for organism-wide energy storage
in vivo and therefore not a potential target for the treatment of
obesity, a condition associated with increased risk for age-related
diseases and associated with a shortened lifespan24. Alternative
mechanismsmust exist that regulate the balance between organismal
energy uptake and usage.
Our data are consistent with the following model of b2oxidation:
(A) In wild type animals b2oxidation occurs in different tissues:
TAG do not accumulate and enough energy is provided for survival.
(B) When b2oxidation is ubiquitously impaired (such as in heredit-
ary diseases), not enough energy can be provided leading to orga-
nismal dysfunction and death. In these situations TAG accumulate
in the brain. (C) Allowing the animals with reduced (blocked)
b2oxidation to perform b2oxidation specifically in glia results in
energy production fromLCFAb2oxidation and the export of ketone
bodies to other tissues. This reverses TAG accumulation and pre-
vents death. In support, a number of publications have reported that
fatty acid oxidation/ketone body formation play a protective role.
The brain is a privileged organ in terms of substrate use for cellular
energy production25. However, the brain is not completely but only
relatively different from body cells, because in case of absolute need it
is also capable of catabolizing LCFA for its own and even for systemic
needs. This becomes relevant in ageing or obese organisms, where
the substrate restriction might be increasingly loosened and
b2oxidation less repressed26, as indicated by increasing expression
of b2oxidation genes in ageing brains27,28. This might contribute to
ageing phenotypes of the brain and increasing prevalence of age-
related neurodegenerative diseases such as Alzheimer or Parkinson
disease.
Methods
Stocks. P(GSV7)GS21694, CPT1 EY20655/CyO, Df(3l)BSC428, Df(3L)BSC671 were
received from Bloomington stock center. UAS . LSD2-GFP was received from R.
Ku¨hnlein (MPI Go¨ttingen); Repo-Gal4, Mef2-Gal4, Cg-Gal4, Nsyb-Gal4, NP 2222,
Nrv2-Gal4, NP6520 and Eaat-Gal4 were received from M. Koch (VIB, Leuven).
Flies were raised on standard cornmeal molasses fly food29 and kept at 25C in a
12 h light/dark cycle.
dCPT2d18 and dCPT2d3 flies were generated by imprecise excision of
P(GSV7)GS21694, located 92 bp upstream from the transcriptional start site of
CG2107. dCPT2d18 is a 456 bp deletion of CG2107 exon 1. dCPT2d3 is a 3224 bp
deletion of the 59UTR and the first 505 amino acids of theCG2107ORF. dCPT2Rev is a
complete revertant and was used as control line. For targeted knockdown of dCPT2,
UAS-line CG2107R2 from the NIG stock center was driven by Nsyb-Gal4 or
Repo-Gal4.
Rescue constructs. Rat CPT2 cDNA was cloned into the EcoRI site of pUAST and
checked for orientation. The H371A mutation was generated by site directed
mutagenesis and the cDNA was recloned into pUAST.
cDNAwas cloned into pH-Pelicanwith themammalianHsp70 promoter andUAS
binding sites. All constructs were verified by sequencing the complete insert and
introduced into the germline by standard P-element mediated transformation.
dCPT2-GFP knock-in. The knock-in of GFP has been performed by the fosmid
taggingmethod of Ejsmont et al. 200930. In brief, fosmid pFlyFos 015048, a clone from
a genomic fosmid library containing an AttB sequence recognized by QC31 integrase,
the eye promoter–driven dominant selectable marker dsRed for isolation of
transformants, and a 40 kb genomic sequence flanking dCPT2 was used to
C-terminally tag dCPT2 with super folder GFP by recombineering. The modified
fosmid was verified by sequencing the tag-fosmid junction and injected into the
germline ofDrosophila melanogasterAttP2 flies. Revertant flies were selected with the
help of dsRed driven in the adult eye.
www.nature.com/scientificreports
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Lipid droplet staining. Adult brains were dissected in ice-cold PBS, fixed in 4%
paraformaldehyde for 15 min, washed 33 in PBS. Neutral Lipid Stain (HCS
LipidTOX red neutral lipid stain, Molecular Probes, Eugene, Oregon) was added
151000 in PBS for 30 min light protected at room temperature, brains were 33
washed, mounted in PBS and analyzed directly in a Biorad Radiance confocal
microscope at 594 nm.
qPCR. RNA was extracted from adult fly brains using Trizol. cDNA was synthesized
with RevertAid First Strand cDNA Synthesis Kit using random primers. Quantitative
PCR was performed with Light Cycler and SYBR green according to the
manufacturer’s protocol (Roche, Basel, Switzerland). Primers were designed to span
an intron. Relative expression levels were quantified using the 22DDCt method.
act5c AGTCCGGCCCCTCCATT, CTGATCCTCTTGCCCAGACAA,
HNF4 CTGTCCAGATCCCCTTGTGT; GGCAGGATGAGCAGAATCTC,
SREBP AAGCTGAACAAGTCCGCAGT; CGCTTCTTGGATGCTCTACC,
PEPK GTGCCATCAACCCAGAGAAT; GCCCAACCAGTCAGTGATTT,
ACC CG11198 TAACAACGGAGTCACCCACA,
CAGGTCACAACCGATGTACG,
HMG-CoA lyase TCAACCAATTGTCCGAAACA,
AGCACTCTCGAATCCCTTCA,
HMG-CoA synthase TGGTGTCTCTGTTGATTAGCG,
CTGATCGAGTACATGGAAGCAG, CG1140 CCTCATACTTTGGCTCCGATG,
CCACCCATTCCCTTAACCAG,
CG13377 AGTGTGGTCGCTTTGGATAC, CCGCTCGATCACATGAAGAG,
Lethality. Homozygous larvae were collected and added to a new food vial at
non-crowded density. The percentage of eclosed flies was assessed.
Elextron microscopy. Adult brains were fixed in 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1 M Na-cacodylate buffer pH7.4 for 2 hours at room
temperature andwashed in 0.1 MNa-cacodylate buffer. Then, theywere post-fixed in
1% osmiumtetroxide/H2O for 2 hours, dehydrated in a graded ethanol series and
stained in uranyl acetate/70% ethanol. Finally, the samples were infiltrated with 151
mixture of epoxy resin (Agar100)5propylene oxide for 60 min at 4uC and left
overnight in 251 mixture agar5propylene oxide, embedded and polymerized for 2
days in 100% agar. Finally, 50–60 nm sections were cut with a Leica UCT
ultramicrotome and post-stained with uranyl acetate for 10 min and lead citrate for
3.5 min. Brains were examined and photographed using a transmission electron
microscope JEOL JEM-1400, equipped with a 2 k3 2 k Veleta (Olympus SIS, Tokyo,
Japan) camera.
Western blot. Flies were killed by freezing, homogenized with 10 strokes of an
Eppendorf pestle in a buffer containing 1% Triton X 100, and spun for 10 min at
maximum speed in a table top centrifuge at 4C. The supernatant was diluted to 2 ug/
ul protein content, boiled in SDS sample buffer, loaded on a Tris gel, transferred to a
nitrocellulose membrane, blocked in non-fat dry milk, and visualized with 151000
anti-CPT2 (H-300 from Santa Cruz), a rabbit polyclonal antibody raised against
amino acids 51–350 of human CPT2, or 151000 anti-Histone 3 (#9715 from Cell
Signaling) as loading control.
Life span. Flies were collected after birth and kept at 25uC in a humidified incubator
with 12 hour light/dark cycle on regular corn molasses fly food. The vials were
changed 3 times per week. Dead flies were scored every day.
Starvation. One week old flies (n .5 80) were kept on 1% agarose at 25uC in a
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Lipid analysis. Lipids were extracted from flies or brains with a modified Bligh &
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